港股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

生物醫藥B類股

717.887

+1.9210.27%

漲家數：14

跌家數：17

平家數：3

市盈率：- -

高：728.504

開：715.966

低：704.159

收：715.966

成交量：9,293.30萬

成交額：33.79億

市值：4,596.50億

流通市值：4,080.94億

資料載入中...

總覽新聞資訊

短線風險連續釋放後或存修復預期

基金忠言｜中歐葛蘭發信號，創新藥基金有機會

【今日主題前瞻】氫能下游應用路徑正逐步清晰，產業或迎規模化和商業化轉折點

機構觀點偏向保守創新藥成最強主線 | 權益市場周報

东方财富Choice...

醫藥突然「變臉」，發生了什麼？華寶基金港股通創新藥ETF（520880）周線逆市連陽！

資產負債率超九成、淨利預計連虧三年，海南海藥擬減持中國抗體股份套現

2025年中國創新藥上市公司收入突破1000億元我們離全球「領跑」還有多遠？

每日经济新闻

廣生堂最新公告：乙肝創新藥尚處於在研階段

1月翻倍！又有創新藥妖股誕生

強勢反彈！創新藥業績盈利周期開啓，BD出海狂飆突進

鉅虧4.37億元，股價反飆20％：基石藥業「斷臂」後的豪賭

黃南州24項傳統藏醫藥技藝列入非遺名錄

海南海藥擬減持中國抗體不超5%股份，可套現最高約1.20億港元，公司去年減虧至最多4.3億元

深圳商报·读创

突然殺回來了！創新藥ETF大盤點！

那曲西部四縣協同推進藏醫藥發展，申扎縣藏醫院創級升級

中国西藏新闻网

豬價探底背後：行業全鏈有望重塑

中国经营网

諾誠健華（688428）披露證券變動月報表，4月3日股價下跌1.9%

海南海藥擬減持中國抗體股份數量不超過6800萬股

深度觀察｜從「燒錢」走向「賺錢」，2025年中國創新藥上市公司收入突破1000億元，我們離全球「領跑」還差多遠?

每日经济新闻

海南海藥擬減持中國抗體不超5%股份

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/BK1574/news?page=12"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK1574","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1574\",,,,,undefined,":{"symbol":"BK1574","market":"HK","secType":"PLATE","nameCN":"生物醫藥B類股","latestPrice":717.8865,"timestamp":1776411490569,"preClose":715.96594,"halted":0,"volume":92931953,"delay":0,"changeRate":0.002682,"floatShares":0,"shares":0,"eps":0,"marketStatus":"交易中","change":1.920532,"latestTime":"04-17 15:38:10","open":715.96594,"high":728.5041,"low":704.15936,"amount":3379300544,"amplitude":0.034003,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"收盤","tradingStatus":0,"beginTime":1776413400000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1776389400000,1776398400000],[1776402000000,1776412800000]],"pbRate":5.627353,"peRate":-94.073273,"turnoverRate":0.003388,"increases":14,"decrements":17,"flats":2,"marketCap":459650145216,"floatMarketCap":408093604432},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1574\",,,,,undefined,":{"symbol":"BK1574","high":728.5041,"amplitude":0.034003,"preClose":715.96594,"low":704.15936,"pbRate":"5.627353","latestPrice":717.8865,"volume":92932953,"delay":0,"open":715.96594,"prevYearClose":556.26263,"prevWeekClose":666.249,"prevMonthClose":610.821,"prevQuarterClose":610.821,"fiveDayClose":666.249,"twentyDayClose":575.488,"sixtyDayClose":612.872,"secType":"PLATE","market":"HK","turnoverRate":0.003388,"peRate":-94.073273,"marketCap":459650145216,"floatMarketCap":408093604432,"timestamp":1776411490765,"nameCN":"生物醫藥B類股"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK1574\",,,,undefined,":{"bkCode":"BK1574","up":14,"down":17,"flat":3},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK1574\",pageSize:20,pageCount:12,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2625798371","title":"短線風險連續釋放後或存修復預期","url":"https://stock-news.laohu8.com/highlight/detail?id=2625798371","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625798371?lang=zh_tw&edition=fundamental","pubTime":"2026-04-07 09:21","pubTimestamp":1775524861,"startTime":"0","endTime":"0","summary":"导读：①光通信板块逆势走强，OCS方向受政策与产业前景催化爆发，光纤链持续走强，后续关注板块内结构性轮动；②创新药虽分化但活跃度高，行业进入创新与盈利周期，调整充分具备避险属性，后市机会或向核心龙头集中；③4月进入年报及一季报密集披露期，业绩将成市场核心驱动主线。不过，消息面假期的缘冲突风险暂无进一步恶化，外围市场以小幅上涨为主，结合A股连续风险释放后短线情绪趋于冰点，后续可能存在一定的修复预期。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/zldongxiang/20260407/32127328.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK1161","BK1574","06978"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625983319","title":"基金忠言｜中歐葛蘭發信號，創新藥基金有機會","url":"https://stock-news.laohu8.com/highlight/detail?id=2625983319","media":"蓝鲸财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625983319?lang=zh_tw&edition=fundamental","pubTime":"2026-04-07 08:56","pubTimestamp":1775523400,"startTime":"0","endTime":"0","summary":"在年报中，她详细阐述了中国创新药产业基本面的情况，表示仍旧看好创新药产业链。2025年，创新药BD交易总金额为1388亿美元，占全球的约一半。近期医药生物板块表现较好，中欧基金权益研究部医药组对此表示，主要驱动因素来自创新药板块的强势表现。至于葛兰为什么选择增持医疗创新，而不是另外两只基金，中欧基金没有予以说明。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.lanjinger.com/d/1775522638529147830","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"lanjinger_stock","symbols":["06978","BK1574","BK1161","159992"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625498830","title":"【今日主題前瞻】氫能下游應用路徑正逐步清晰，產業或迎規模化和商業化轉折點","url":"https://stock-news.laohu8.com/highlight/detail?id=2625498830","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625498830?lang=zh_tw&edition=fundamental","pubTime":"2026-04-07 08:13","pubTimestamp":1775520809,"startTime":"0","endTime":"0","summary":"　　据媒体报道，受地缘局势紧张影响，国际油价近期大幅上涨，新能源的重要性进一步凸显。其中，氢能由于既能消化上游富余的绿电，又能向下游提供清洁高效的能源，被寄予厚望。氢能下游应用的路径正逐步清晰，将从价格敏感度最低的交通和化工领域率先突破，沿着“绿色航运、氢能重卡、化工、冶金、储能”的路径推进。国金证券指出，作为未来国家能源体系的重要组成部分，氢能正站在规模化和商业化的历史转折点上。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/shichangceping/20260407/32127274.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK1161","06978","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625607020","title":"機構觀點偏向保守 創新藥成最強主線 | 權益市場周報","url":"https://stock-news.laohu8.com/highlight/detail?id=2625607020","media":"东方财富Choice...","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625607020?lang=zh_tw&edition=fundamental","pubTime":"2026-04-07 07:05","pubTimestamp":1775516700,"startTime":"0","endTime":"0","summary":"AI摘要：二季度A股宜均衡配置，兼顾AI、新能源等高景气成长、周期资源与高股息标的，资金偏好防御+结构性机会。创新药板块迎盈利拐点，出海提速，核药等前沿赛道热度攀升。美国重启载人探月，也带动国内商业航天产业链加速发展，行业有望迎来万亿级增长机遇。上周，A股三大指数全线回调，沪指下跌0.86%，深证成指下跌2.96%，创业板指下跌4.44%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202604073695938245.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["06978","BK1161","BK1574","159992"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625679133","title":"醫藥突然「變臉」，發生了什麼？華寶基金港股通創新藥ETF（520880）周線逆市連陽！","url":"https://stock-news.laohu8.com/highlight/detail?id=2625679133","media":"新浪基金","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625679133?lang=zh_tw&edition=fundamental","pubTime":"2026-04-06 20:02","pubTimestamp":1775476920,"startTime":"0","endTime":"0","summary":"4月3日，A股高开低走，沪指续跌1%再失3900点。近期炙手可热的医药板块突发调整，全市场规模最大医疗ETF华宝收跌2.65%失守20日线，场内唯一药ETF华宝跌1.45%止步两连阳。　　港股因耶稣受难节假期休市，港股通创新药ETF华宝、港股通医疗ETF华宝在A股的交易价格完全由资金博弈决定，今日同跌1%左右。　　医药突然“变脸”，发生了什么？　　消息一出，引发市场高度关注。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/money/fund/etf/2026-04-06/doc-inhtqnru4217751.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["159938","520880","09939","BK1515","BK1161","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625148676","title":"資產負債率超九成、淨利預計連虧三年，海南海藥擬減持中國抗體股份套現","url":"https://stock-news.laohu8.com/highlight/detail?id=2625148676","media":"北京商报","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625148676?lang=zh_tw&edition=fundamental","pubTime":"2026-04-06 19:14","pubTimestamp":1775474084,"startTime":"0","endTime":"0","summary":"海南海药（000566）拟出售股票资产。海南海药最新公告显示，公司拟通过集中竞价交易及大宗交易的方式减持公司目前持有的港股上市公司中国抗体（03681.HK）股份数量不超过6800万股，占其总股本的比例不超过5%。资料显示，中国抗体成立于2001年4月，注册地为香港，于2019年11月在港交所上市，截至目前其总股本为13.87亿股。中国抗体主要研制以单克隆抗体为基础的生物药。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202604063695802525.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202604063695802525.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK0188","BK0146","03681","BK0239","000566","BK0070","BK1574","BK0060","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625676541","title":"2025年中國創新藥上市公司收入突破1000億元 我們離全球「領跑」還有多遠？","url":"https://stock-news.laohu8.com/highlight/detail?id=2625676541","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625676541?lang=zh_tw&edition=fundamental","pubTime":"2026-04-06 19:02","pubTimestamp":1775473345,"startTime":"0","endTime":"0","summary":"随着2025年各家上市公司年报密集出炉，中国创新药产业的结构性变革正式浮出水面。据《每日经济新闻》记者（以下简称每经记者）不完全统计，百济神州、信达生物、华领医药、诺诚健华、乐普生物、荣昌生物、迈博药业、北海康成等公司扭亏为盈。创新药企终于从“烧钱”走向“赚钱”。与此同时，中国已跃升为全球创新药优质在研管线的核心供给地。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202604063695802194.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202604063695802194.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["06978","BK1161","BK1574","159992"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625789476","title":"廣生堂最新公告：乙肝創新藥尚處於在研階段","url":"https://stock-news.laohu8.com/highlight/detail?id=2625789476","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625789476?lang=zh_tw&edition=fundamental","pubTime":"2026-04-06 16:43","pubTimestamp":1775464998,"startTime":"0","endTime":"0","summary":"广生堂(300436.SZ)公告称，公司股票自2026年4月1日至4月3日连续三个交易日收盘价格涨幅偏离值累计超过30%，属于股票交易异常波动。公司乙肝创新药尚处于在研阶段。创新药研发周期长，投入大，风险高，容易受到多方面因素的影响，临床研究存在结果不及预期甚至失败的风险，后续能否获得批准上市存在不确定性，短期内对公司业绩不会产生重大影响。敬请广大投资者谨慎决策，注意防范投资风险。为证券之星据公开信息整理，由AI算法生成(网信算备310104345710301240019号)，不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushiyaowen/20260406/32126758.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["300436","BK1574","06978","159992","BK1161","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625923649","title":"1月翻倍！又有創新藥妖股誕生","url":"https://stock-news.laohu8.com/highlight/detail?id=2625923649","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625923649?lang=zh_tw&edition=fundamental","pubTime":"2026-04-05 17:45","pubTimestamp":1775382327,"startTime":"0","endTime":"0","summary":"3月创新药妖股频出，意味着什么信号?","market":"sh","thumbnail":"https://img3.gelonghui.com/6f3f2-0470ab12-a8ce-4d28-b30d-2aaf0d2afce5.jpg?guru_height=717&guru_width=1280&guru_size=209034","type":0,"news_type":0,"thumbnails":["https://img3.gelonghui.com/6f3f2-0470ab12-a8ce-4d28-b30d-2aaf0d2afce5.jpg?guru_height=717&guru_width=1280&guru_size=209034"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/p/4310631","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"gelonghui_highlight","symbols":["BK1161","BK0004","002082","BK0050","06978","BK0028","159992","BK1574","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625964824","title":"強勢反彈！創新藥業績盈利周期開啓，BD出海狂飆突進","url":"https://stock-news.laohu8.com/highlight/detail?id=2625964824","media":"券商中国","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625964824?lang=zh_tw&edition=fundamental","pubTime":"2026-04-05 11:38","pubTimestamp":1775360280,"startTime":"0","endTime":"0","summary":"经历了将近半年的大幅调整，创新药指数近期明显反弹。Wind创新药概念指数在过去1个月上涨了8.47%，同期沪深300指数下跌了4.62%。机构分析指出，创新药板块当前具备宏观资金面与产业基本面的双重支撑：一方面，美债收益率与A股创新药行情呈现显著的负相关关系，美债收益率拐点往往亦是创新药行情的拐点；另一方面，创新药出海持续放量，基本面韧性强劲。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202604053695665449.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["06978","159992","BK1574","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625171546","title":"鉅虧4.37億元，股價反飆20％：基石藥業「斷臂」後的豪賭","url":"https://stock-news.laohu8.com/highlight/detail?id=2625171546","media":"华夏时报","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625171546?lang=zh_tw&edition=fundamental","pubTime":"2026-04-05 08:35","pubTimestamp":1775349300,"startTime":"0","endTime":"0","summary":"华夏时报记者郭怡琳于娜北京报道近日，基石药业发布2025年度财报，全年收入2.70亿元，同比下降33.8%；年内亏损扩大至4.37亿元，较上年同期的9120万元亏损增加3.46亿元，亏损同比扩大3.79倍。这是基石药业自2019年上市以来亏损额最高的一份年报。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202604053695649372.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202604053695649372.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["06978","BK1161","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625158176","title":"黃南州24項傳統藏醫藥技藝列入非遺名錄","url":"https://stock-news.laohu8.com/highlight/detail?id=2625158176","media":"青海日报","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625158176?lang=zh_tw&edition=fundamental","pubTime":"2026-04-05 00:39","pubTimestamp":1775320740,"startTime":"0","endTime":"0","summary":"据悉，此次列入非遗名录的项目涵盖传统藏医药剂炮制、藏医药储存和加工技术、藏药浴、藏式按摩等特色康养养生方法。这一成果是对黄南州中藏医药文化传承工作的充分肯定，也为守护民族文化基因、传承民族智慧结晶提供了有力保障。今年以来，黄南州严格落实中央及青海省委、省政府关于扶持中医药事业发展的各项部署。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/jjxw/2026-04-05/doc-inhtkett7713522.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1574","09939","BK1161","BK1515","159938"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624618445","title":"海南海藥擬減持中國抗體不超5%股份，可套現最高約1.20億港元，公司去年減虧至最多4.3億元","url":"https://stock-news.laohu8.com/highlight/detail?id=2624618445","media":"深圳商报·读创","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624618445?lang=zh_tw&edition=fundamental","pubTime":"2026-04-04 22:08","pubTimestamp":1775311698,"startTime":"0","endTime":"0","summary":"4月3日，海南海药（000566）发布公告，公司拟通过集中竞价交易及大宗交易的方式减持中国抗体（03681）股份数量不超过6800万股，不超过公司总股本的5%。中国抗体系公司参股企业，公司持有中国抗体15888.21万股股份，占其总股本的11.46%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202604043695624954.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK0070","03681","BK1574","BK0239","BK0146","BK1161","000566","BK0188","BK0060"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624695134","title":"突然殺回來了！創新藥ETF大盤點！","url":"https://stock-news.laohu8.com/highlight/detail?id=2624695134","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624695134?lang=zh_tw&edition=fundamental","pubTime":"2026-04-04 11:35","pubTimestamp":1775273728,"startTime":"0","endTime":"0","summary":"图解创新药主题ETF","market":"sh","thumbnail":"https://img3.gelonghui.com/a0989-a422cedf-f15d-459f-90fa-e7074c8daf48.jpg?guru_height=2241&guru_width=3280&guru_size=1441563","type":0,"news_type":0,"thumbnails":["https://img3.gelonghui.com/a0989-a422cedf-f15d-459f-90fa-e7074c8daf48.jpg?guru_height=2241&guru_width=3280&guru_size=1441563"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/p/4307632","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"gelonghui_fund_highlight","symbols":["LU1969619763.USD","LU1770034418.SGD","LU1719994722.HKD","BK1583","BK1588","LU0307460666.USD","LU0588546209.SGD","LU2328871848.SGD","BK1500","06978","LU1303224171.USD","BK1161","BK1574","LU1251922891.USD","06160"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624986346","title":"那曲西部四縣協同推進藏醫藥發展，申扎縣藏醫院創級升級","url":"https://stock-news.laohu8.com/highlight/detail?id=2624986346","media":"中国西藏新闻网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624986346?lang=zh_tw&edition=fundamental","pubTime":"2026-04-04 08:46","pubTimestamp":1775263560,"startTime":"0","endTime":"0","summary":"2024年8月，申扎县藏医院成功创建二级乙等民族医院，率先在西部四县藏医院中完成创级工作。筛选四县专家库人才共18人，后备人才库共26人，在申扎县举办西部四县藏医技术骨干培训班、乡村藏医技术骨干培训班，累计培训藏医骨干和专技人员60余人次。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/jjxw/2026-04-04/doc-inhthssm8316395.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["159938","09939","BK1161","BK1515","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624662148","title":"豬價探底背後：行業全鏈有望重塑","url":"https://stock-news.laohu8.com/highlight/detail?id=2624662148","media":"中国经营网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624662148?lang=zh_tw&edition=fundamental","pubTime":"2026-04-04 03:58","pubTimestamp":1775246320,"startTime":"0","endTime":"0","summary":"供需波动导致我国生猪价格持续下探，进而引发行业内外的广泛讨论。数据显示，截至3月底，全国外三元生猪均价在9.4元/公斤左右，同比降幅30%，比年初水平下降20%。多位行业人士告诉《中国经营报》记者，按全国平均水平，当前生猪养殖完全成本仍在13元/公斤左右，按出栏体重125公斤推算，意味着头均亏损450元左右。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202604043695328679.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK0070","BK1161","002714","BK0240","BK0183","BK0187","BK0195","BK0056","BK0028","BK0238","BK0197","BK0012","002567","000876","02137","LU1655091616.SGD","BK0039","300498","02714","002458","BK1237","BK0194","BK0077","002124","BK1574","BK0188","BK0201","BK0196","BK1587"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2624566806","title":"諾誠健華（688428）披露證券變動月報表，4月3日股價下跌1.9%","url":"https://stock-news.laohu8.com/highlight/detail?id=2624566806","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624566806?lang=zh_tw&edition=fundamental","pubTime":"2026-04-03 22:12","pubTimestamp":1775225533,"startTime":"0","endTime":"0","summary":"近日，诺诚健华发布港股公告《证券变动月报表》。公告显示，截至2026年3月31日，公司法定注册资本无变动，已发行股份总数与上月底结存一致，无增减。此外，2023年及2024年人民币股股权激励计划项下部分限制性股票失效，但本月未因协议安排导致股份增减。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushiyaowen/20260403/32125629.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK1161","BK0239","09969","161027","688428","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624016650","title":"海南海藥擬減持中國抗體股份數量不超過6800萬股","url":"https://stock-news.laohu8.com/highlight/detail?id=2624016650","media":"北京商报","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624016650?lang=zh_tw&edition=fundamental","pubTime":"2026-04-03 21:14","pubTimestamp":1775222054,"startTime":"0","endTime":"0","summary":"北京商报讯（记者丁宁）4月3日晚间，海南海药（000566）发布公告称，公司拟通过集中竞价交易及大宗交易的方式减持公司目前持有的中国抗体制药有限公司（HK03681，以下简称“中国抗体”）股份数量不超过6800万股（占其总股本的比例不超过5%）。公告显示，中国抗体系公司参股企业，海南海药持有中国抗体15888.21万股股份，占其总股本的11.46%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202604033695195266.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202604033695195266.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1161","000566","BK1574","BK0188","BK0070","BK0060","03681","BK0146","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624502586","title":"深度觀察｜從「燒錢」走向「賺錢」，2025年中國創新藥上市公司收入突破1000億元，我們離全球「領跑」還差多遠?","url":"https://stock-news.laohu8.com/highlight/detail?id=2624502586","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624502586?lang=zh_tw&edition=fundamental","pubTime":"2026-04-03 21:06","pubTimestamp":1775221600,"startTime":"0","endTime":"0","summary":"随着2025年各家上市公司年报密集出炉，中国创新药产业的结构性变革，正式浮出水面。《每日经济新闻》记者不完全统计，百济神州、信达生物、华领医药、诺诚健华、乐普生物、荣昌生物、迈博药业、北海康成等公司扭亏为盈。创新药企终于从“烧钱”走向“赚钱”，与此同时，中国已跃升为全球创新药优质在研管线的核心供给地。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202604033695191747.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202604033695191747.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1161","159992","BK1574","06978"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624500126","title":"海南海藥擬減持中國抗體不超5%股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2624500126","media":"财中社","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624500126?lang=zh_tw&edition=fundamental","pubTime":"2026-04-03 20:57","pubTimestamp":1775221020,"startTime":"0","endTime":"0","summary":"4月3日，海南海药（000566）发布公告，公司拟通过集中竞价交易及大宗交易的方式减持中国抗体（03681）股份数量不超过6800万股，不超过公司总股本的5%。截至公告披露日前一交易日，公司持有中国抗体1.59亿股股票资产的市值约为2.8亿港元，此次交易旨在优化公司资产结构，提高资产流动性及使用效率。2025年前三季度，海南海药实现收入6.40亿元，归母净利润-2.42亿元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202604033695191451.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK0188","BK1574","BK0070","BK0060","000566","BK1161","03681","BK0146","BK0239"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":13,"pageCount":12,"totalSize":247,"code":"91000000","status":"200"}]}}